What is the current Price Target for the Inmune Bio, Inc. stock?

The average Inmune Bio, Inc. target price is $23.33. This is 189.14% higher than the current stock price. The highest price target is 271.75%, the lowest is 147.83%. 6 Analysts have issued a price target Inmune Bio, Inc. 2026 .

How high will the Inmune Bio, Inc. stock rise?

No reliable answer can be given as to how high the Inmune Bio, Inc. stock will rise. The performance of stocks, including the Inmune Bio, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Inmune Bio, Inc. stock today?

The performance of Inmune Bio, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Inmune Bio, Inc. stock fall?

The decline in Inmune Bio, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Inmune Bio, Inc. Forecast, price target & analysts

$7.84

2.85% today

Nasdaq, Apr 03, 06:48 pm CET

ISIN

US45782T1051

Symbol

INMB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Inmune Bio, Inc. Target price 2025 - Analyst rating & recommendation

Inmune Bio, Inc. Classifications & Recommendation:

Buy

100%

Inmune Bio, Inc. Price Target

Target Price	$23.33
Price	$8.07
Potential	189.14% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Inmune Bio, Inc. 2026 . The average Inmune Bio, Inc. target price is $23.33. This is 189.14% register free of charge higher than the current stock price. The highest price target is $30.00 271.75% register free of charge , the lowest is $20.00 147.83% register free of charge .
	A rating was issued by 6 analysts: 6 Analysts recommend Inmune Bio, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Inmune Bio, Inc. stock has an average upside potential 2026 of 189.14% register free of charge . Most analysts recommend the Inmune Bio, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.11	-1.82
	26.35%	13.74%
P/E		negative

4 Analysts have issued a Inmune Bio, Inc. forecast for earnings per share. The average Inmune Bio, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.11	26.35%
2025	$-1.82 13.74% Unlock
2026	$-1.74 4.40% Unlock
2027	$-1.30 25.29% Unlock
2028	$-0.99 23.85% Unlock
2029	$0.76 176.77% Unlock

Current	-3.79	50.72%
2025	-4.43 16.89% Unlock
2026	-4.65 4.97% Unlock
2027	-6.21 33.55% Unlock
2028	-8.18 31.72% Unlock
2029	10.57 229.22% Unlock

Inmune Bio, Inc....

Current Inmune Bio, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Maxim Group	Locked ➜ Locked	Locked	Feb 13 2025
Scotiabank	Locked ➜ Locked	Locked	Feb 11 2025
Alliance Global Partners	Locked ➜ Locked	Locked	Oct 21 2024
Raymond James	Locked ➜ Locked	Locked	Sep 27 2024
Scotiabank	Locked ➜ Locked	Locked	Aug 22 2024

Analyst Rating	Date
Locked Maxim Group: Locked ➜ Locked	Feb 13 2025
Locked Scotiabank: Locked ➜ Locked	Feb 11 2025
Locked Alliance Global Partners: Locked ➜ Locked	Oct 21 2024
Locked Raymond James: Locked ➜ Locked	Sep 27 2024
Locked Scotiabank: Locked ➜ Locked	Aug 22 2024

Discover more stocks with a high price target

Novo Nordisk 75.12%

Coinbase Global, Inc. 71.30%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now